|
1
|
Grossman SA, Ye X, Piantadosi S, et al:
Survival of patients with newly diagnosed glioblastoma treated with
radiation and temozolomide in research studies in the United
States. Clin Cancer Res. 16:2443–2449. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Johnson DR, Ma DJ, Buckner JC and Hammack
JE: Conditional probability of long-term survival in glioblastoma:
a population-based analysis. Cancer. 118:5608–5613. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lacroix M, Abi-Said D, Fourney DR, et al:
A multivariate analysis of 416 patients with glioblastoma
multiforme: prognosis, extent of resection, and survival. J
Neurosurg. 95:190–198. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sanai N, Polley M, McDermott M, Parsa A
and Berger M: An extent of resection threshold for newly diagnosed
glioblastomas. J Neurosurg. 115:3–8. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Westphal M, Hilt D, Bortey E, et al: A
phase 3 trial of local chemotherapy with biodegradable carmustine
(BCNU) wafers (Gliadel wafers) in patients with primary malignant
glioma. Neuro Oncol. 5:79–88. 2003.PubMed/NCBI
|
|
6
|
Fleming A and Saltzman W: Pharmacokinetics
of the carmustine implant. Clin Pharmacokinet. 41:403–419. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Aboody K, Brown A, Rainov NG, et al:
Neural stem cells display extensive tropism for pathology in adult
brain: evidence from intracranial gliomas. Proc Natl Acad Sci USA.
97:12846–12851. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lee J, Elkahloun AG, Messina SA, et al:
Cellular and genetic characterization of human adult bone
marrow-derived neural stem-like cells: a potential antiglioma
cellular vector. Cancer Res. 63:8877–8889. 2003.PubMed/NCBI
|
|
9
|
Amano S, Li S, Gu C, et al: Use of
genetically engineered bone marrow-derived mesenchymal stem cells
for glioma gene therapy. Int J Oncol. 35:1265–1270. 2009.PubMed/NCBI
|
|
10
|
Li S, Tokuyama T, Yamamoto J, Koide M,
Yokota N and Namba H: Bystander effect-mediated gene therapy of
gliomas using genetically engineered neural stem cells. Cancer Gene
Ther. 12:600–607. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li S, Gao Y, Tokuyama T, et al:
Genetically engineered neural stem cells migrate and suppress
glioma cell growth at distant intracranial sites. Cancer Lett.
251:220–227. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Amano S, Gu C, Koizumi S, Tokuyama T and
Namba H: Tomoricidal bystander effect in the suicide gene therapy
using mesenchymal stem cells does not injure normal brain tissues.
Cancer Lett. 306:99–105. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bovenberg MS, Degeling MH and Tannous BA:
Advances in stem cell therapy against gliomas. Trends Mol Med.
19:281–291. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nishikawa S, Goldstein RA and Nierras CR:
The promise of human induced pluripotent stem cells for research
and therapy. Nat Rev Mol Cell Biol. 9:725–729. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Okita K, Ichisaka T and Yamanaka S:
Generation of germline-competent induced pluripotent stem cells.
Nature. 448:313–317. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Koizumi S, Gu C, Amano S, et al: Migration
of mouse-induced pluripotent stem cells to glioma-conditioned
medium is mediated by tumor-associated specific growth factors.
Oncol Lett. 2:283–288. 2011.PubMed/NCBI
|
|
17
|
Takahashi K, Okita K, Nakagawa M and
Yamanaka S: Induction of pluripotent stem cells from fibroblast
cultures. Nat Protoc. 2:3081–3089. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lee E, Lam D, Wu C, et al: Glioma gene
therapy using induced pluripotent stem cell derived neural stem
cells. Mol Pharm. 8:1515–1524. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Onorati M, Camnasio S, Binetti M, Jung CB,
Moretti A and Cattaneo E: Neuropotent self-renewing neural stem
(NS) cells derived from mouse induced pluripotent stem (iPS) cells.
Mol Cell Neurosci. 43:287–295. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Pellegatta S, Poliani PL, Corno D, et al:
Neurospheres enriched in cancer stem-like cells are highly
effective in eliciting a dendritic cell-mediated immune response
against malignant gliomas. Cancer Res. 66:10247–10252. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yu SC, Ping YF, Yi L, et al: Isolation and
characterization of cancer stem cells from a human glioblastoma
cell line U87. Cancer Lett. 265:124–134. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gao Y, Gu C, Li S, et al: p27 modulates
tropism of mesenchymal stem cells toward brain tumors. Exp Ther
Med. 1:695–699. 2010.PubMed/NCBI
|
|
23
|
Tang X, Falls DL, Li X, Lane T and Luskin
MB: Antigen-retrieval procedure for bromodeoxyuridine
immunolabeling with concurrent labeling of nuclear DNA and antigens
damaged by HCl pretreatment. J Neurosci. 27:5837–5844. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Aboody K, Najbauer J and Danks M: Stem and
progenitor cell-mediated tumor selective gene therapy. Gene Ther.
15:739–752. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li S, Tokuyama T, Yamamoto J, Koide M,
Yokota N and Namba H: Potent bystander effect in suicide gene
therapy using neural stem cells transduced with herpes simplex
virus thymidine kinase gene. Oncology. 69:503–508. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yang J, Lam DH, Goh SS, et al: Tumor
tropism of intravenously injected human-induced pluripotent stem
cell-derived neural stem cells and their gene therapy application
in a metastatic breast cancer model. Stem Cells. 30:1021–1029.
2012. View Article : Google Scholar
|
|
27
|
Kawai H, Yamashita T, Ohta Y, et al:
Tridermal tumorigenesis of induced pluripotent stem cells
transplanted in ischemic brain. J Cereb Blood Flow Metab.
30:1487–1493. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Pei Z, Lan X, Cheng Z, et al:
Multimodality molecular imaging to monitor transplanted stem cells
for the treatment of ischemic heart disease. PLoS One.
9:e905432014. View Article : Google Scholar : PubMed/NCBI
|
